The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
Endocannabinoids–at the crossroads between the gut microbiota and host metabolism
Abstract
Various metabolic disorders are associated with changes in inflammatory tone. Among the latest advances in the metabolism field, the discovery that gut microorganisms have a major role in host metabolism has revealed the possibility of a plethora of associations between gut bacteria and numerous diseases. However, to date, few mechanisms have been clearly established. Accumulating evidence indicates that the endocannabinoid system and related bioactive lipids strongly contribute to several physiological processes and are a characteristic of obesity, type 2 diabetes mellitus and inflammation. In this Review, we briefly define the gut microbiota as well as the endocannabinoid system and associated bioactive lipids. We discuss existing literature regarding interactions between gut microorganisms and the endocannabinoid system, focusing specifically on the triad of adipose tissue, gut bacteria and the endocannabinoid system in the context of obesity and the development of fat mass. We highlight gut-barrier function by discussing the role of specific factors considered to be putative 'gate keepers' or 'gate openers', and their role in the gut microbiota-endocannabinoid system axis. Finally, we briefly discuss data related to the different pharmacological strategies currently used to target the endocannabinoid system, in the context of cardiometabolic disorders and intestinal inflammation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The ECS and GM interact to regulate intestinal homeostasis resulting in relevant functional effects in the gut and CNS (238, 246, 248, 250).”
From Signalling cognition: The gut microbiota and hypothalamic-pituitary-adrenal axis (2023) · cites this paper as [238]
Citations
Cites
Structure, function and diversity of the healthy human microbiome
The Human Microbiome Project Consortium (2012) · Nature · doi:10.1038/nature11234 · Cited by 11,726
A human gut microbial gene catalogue established by metagenomic sequencing
MetaHIT Consortium, Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K. S., Manichanh, C., Nielsen, T., Pons, N., Levenez, F., et al. (2010) · Nature · doi:10.1038/nature08821 · Cited by 11,624
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Hill (2014) · doi:10.1038/nrgastro.2014.66 · Cited by 9,592
A core gut microbiome in obese and lean twins
Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., Sogin, M. L., Jones, W. J., Roe, B. A., Affourtit, J. P., et al. (2009) · Nature · doi:10.1038/nature07540 · Cited by 7,823
Changes of Intestinal Functions in Liver Cirrhosis
Fukui, H., & Wiest, R. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000444436 · Cited by 6,820
Metabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638
Linking long-term dietary patterns with gut microbial enterotypes
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., et al. (2011) · Science · doi:10.1126/science.1208344 · Cited by 6,513
The gut microbiota as an environmental factor that regulates fat storage
Bäckhed, F., Ding, H., Wang, T., Hooper, L. V., Koh, G. Y., Nagy, A., Semenkovich, C. F., & Gordon, J. I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407076101 · Cited by 6,245
Obesity alters gut microbial ecology
Ley, R. E., Bäckhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., & Gordon, J. I. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504978102 · Cited by 6,176
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 367
Telmisartan induces a specific gut microbiota signature which may mediate its antiobesity effect
Beckmann, L., Künstner, A., Freschi, M. L., Huber, G., Stölting, I., Ibrahim, S. M., Hirose, M., Freitag, M., Langan, E. A., Matschl, U., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105724 · Cited by 16
Wiley, M., & DiPatrizio, N. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810549 · Cited by 15
The endocannabinoid system: a bridge between alzheimer’s disease and gut microbiota
Bisogno, T., Lauritano, A., & Piscitelli, F. (2021) · Life · doi:10.3390/life11090934 · Cited by 16
“In fact, AEA can induce gut permeability, causing a ‘leaky’ gut which in turn lead to the onset of metabolic endotoxemia releasing toxins, including LPS, to cross the epithelial barrier driving inflammatory signaling and affecting the CNS [20].”
BackgroundInfluentialDietary food patterns as determinants of the gut microbiome–endocannabinoidome axis in humans
Castonguay-Paradis, S., Perron, J., Flamand, N., Lamarche, B., Raymond, F., Marzo, V. D., & Veilleux, A. (2023) · Scientific Reports · doi:10.1038/s41598-023-41650-z · Cited by 16
Yin, Z., Wang, K., Liu, Y., Li, Y., He, F., Yin, J., & Tang, W. (2024) · Animals · doi:10.3390/ani14030493 · Cited by 16
Exploring the Gut Microbiota–Muscle Axis in Duchenne Muscular Dystrophy
Mostosi, D., Molinaro, M., Saccone, S., Torrente, Y., Villa, C., & Farini, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115589 · Cited by 16
“Accumulating evidence supports the involvement of endocannabinoids and their receptors in maintaining the gut barrier function, controlling gut permeability, regulating inflammation, and modulating autophagy [93].”
BackgroundManca, C., Lacroix, S., Pérusse, F., Flamand, N., Chagnon, Y. C., Drapeau, V., Tremblay, A., Marzo, V. D., & Silvestri, C. (2021) · Biomedicines · doi:10.3390/biomedicines9091246 · Cited by 15
Kim, D., Min, Y., Yang, J., Heo, Y., Kim, M., Hur, C.-G., Lee, S.-C., Lee, H., Song, K., Heo, J.-Y., et al. (2021) · Animals · doi:10.3390/ani11082309 · Cited by 14
“Cells recognize the peptidoglycan of resident microorganisms mainly via NOD1 or TLR [40].”
BackgroundZakerska‐Banaszak, O., Żuraszek-Szymańska, J., Eder, P., Ladziak, K., Słomski, R., & Skrzypczak-Zielińska, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179589 · Cited by 17
Daniel, N., Barz, M. L., Mitchell, P. L., Varin, T. V., Bourdeau‐Julien, I., Farabos, D., Pilon, G., Gauthier, J., Garofalo, C., Kang, J. X., et al. (2022) · Function · doi:10.1093/function/zqac069 · Cited by 14
β-Caryophyllene: A Therapeutic Alternative for Intestinal Barrier Dysfunction Caused by Obesity
Rodríguez-Mejía, U. U., Paredes, J. M. V., Zepeda‐Morales, A. S. M., Carrera-Quintanar, L., Zepeda-Nuño, J. S., Velázquez‐Juárez, G., Delgado‐Rizo, V., García‐Iglesias, T., Camacho-Padilla, L. G., Varela-Navarro, E., et al. (2022) · Molecules · doi:10.3390/molecules27196156 · Cited by 15
“Cani confirmed these results in his review, distinguishing between ‘gate keepers’ or ‘gate openers’ in terms of the agonists and the abundance of CB2 and CB1 receptors in the intestine, which are associated with serum LPS levels [26].”
ResultCannabis and Endometriosis: The Roles of the Gut Microbiota and the Endocannabinoid System
Farooqi, T., Bhuyan, D. J., Low, M., Sinclair, J., Leonardi, M., & Armour, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12227071 · Cited by 12
“Moreover, as AEA induces gut permeability, its overexpression is thought to cause a “leaky” gut, resulting in metabolic endotoxemia [102].”
BackgroundCannabis and the Gut–Brain Axis Communication in HIV Infection
Wilson, N., Peterson, S. N., & Ellis, R. J. (2020) · Cannabis and Cannabinoid Research · doi:10.1089/can.2020.0037 · Cited by 13
“Other CB1 and CB2 ligands promote increased barrier function (‘‘gatekeepers’’) and reduce inflammation.(88) Enteroendocrine L cells are innervated by enteric glial cells and afferent neurons.”
BackgroundDepommier, C., Flamand, N., Pelicaen, R., Maiter, D. M., Thissen, J., Loumaye, A., Hermans, M. P., Everard, A., Delzenne, N. M., Marzo, V. D., et al. (2021) · Cells · doi:10.3390/cells10010071 · Cited by 13
“While an increasing number of studies began to shed light on the metabolism of these different mediators (for review see [2,18]), the complexity of the eCBome is not fully elucidated, nor its interconnections with other systems.”
BackgroundTreatment of insulin resistance: straight from the gut
Zhang, X., Zheng, X., & Yuan, Y. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.06.016 · Cited by 13
Tambo, A., Roshan, M. H. K., & Pace, N. P. (2016) · International Journal of Chronic Diseases · doi:10.1155/2016/7030795 · Cited by 13
“These systems include the endocannabinoid system, the apelinergic system, and the enteroendocrine system [78, 86].”
BackgroundYang, G., Jiang, A., Cai, H., You, F., Wu, S., Zhang, Y., Zhang, X., Shen, Y., Chang, X., Hu, W., et al. (2023) · Aquaculture · doi:10.1016/j.aquaculture.2023.739465 · Cited by 12
Ellermann, M. (2023) · Advances in Drug and Alcohol Research · doi:10.3389/adar.2023.11359 · Cited by 13
Singh, A. K., Kumar, P., Mishra, S. K., Rajput, V. D., Tiwari, K. N., Singh, A. K., Minkina, T., Pandey, A. K., & Upadhyay, P. (2024) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-024-04879-6 · Cited by 12
“In addition to SCFAs and bacterial toxins, the microbiota may also affect the gut barrier through the endocannabinoid system [27, 28] and the metabolism of bile acids (BAs) [27].”
Impact of prenatal THC exposure on lipid metabolism and microbiota composition in rat offspring
Murru, E., Carta, G., Manca, C., Verce, M., Everard, A., Serra, V., Aroni, S., Melis, M., & Banni, S. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35637 · Cited by 12
“Notably, gut microbes and bioactive metabolites related to the endocannabinoidome (eCBome) have also been identified as important factors modulating systemic inflammation, IR and fat accumulation [18].”
BackgroundNatale, N. R., Kent, M., Fox, N. S., Vavra, D. T., & Lambert, K. G. (2021) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2021.10.004 · Cited by 12
Yang, Y., Tian, A., Wu, Z., Wei, Y., Hu, X., & Guo, J. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6623379 · Cited by 12
“G protein-coupled receptor 5 (TGR5) on enteroendocrine L cells promotes the secretion of, among others, glucagon-like peptide-1 (GLP-1) [16, 17], an incretin hormone that can regulate glucose by exerting insulinotropic action [18].”
BackgroundYuan, Q., Zhu, S., Yue, S., Han, Y., Peng, G., Li, L., Sheng, Y., & Wang, B. (2023) · Nutrients · doi:10.3390/nu15132984 · Cited by 12
“NAEs could be involved in maintaining the homeostasis of the intestinal environment and host metabolism [27], regulate the IM composition and gut barrier function [28], and be effective at activating neuroprotective mechanisms to suppress inflammatory neurodegenerative disease [29].”
BackgroundMethodNishizawa, K. (2016) · Biomedical Research and Clinical Practice · doi:10.15761/brcp.1000110 · Cited by 12
“GLP-1 stimulates insulin secretion, and GLP2 stabilizes intestinal barrier [113,122].”
BackgroundInfluentialValle, M., Mitchell, P. L., Pilon, G., St‐Pierre, P., Varin, T. V., Richard, D., Vohl, M., Jacques, H., Delvin, E., Levy, E. H., et al. (2021) · Journal of Nutrition · doi:10.1093/jn/nxab002 · Cited by 12
“Overactivation of this system also leads to a disrupted gut barrier function (76).”
BackgroundSilva, M. H. (2021) · Current Research in Toxicology · doi:10.1016/j.crtox.2021.08.002 · Cited by 12
Coccurello, R., Marrone, M. C., & Maccarrone, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.869606 · Cited by 12
“In support of the idea of a mutual interconnection between endocannabinoids and microbiota, especially in the regulation of energy metabolism (Cani et al., 2016), it has been pointed out that human microbiota can encode N-acyl amides (i.”
BackgroundBristot, V. J. D. O., Poletto, G., Pereira, D. M. R., Hauck, M., Schneider, I. J. C., & Aguiar, A. S. (2022) · Systematic Reviews · doi:10.1186/s13643-022-01980-x · Cited by 11
“The endocannabinoid system plays a crucial role in the maintenance of homeostasis in thermoregulation and motor control [2], energy metabolism [3], skin function (barrier formation, regeneration) [4], appetite and digestion [5], learning and memory [6], chronic pain [7], and inflammation and other immune system respon…”
BackgroundSalsinha, A. S., Araújo-Rodrigues, H., Dias, C., Cima, A., Rodríguez-Alcalá, L. M., Relvas, J. B., & Pintado, M. (2025) · Clinical Nutrition · doi:10.1016/j.clnu.2025.04.007 · Cited by 13
Using integrated meta-omics to appreciate the role of the gut microbiota in epilepsy
Boeri, L., Donnaloja, F., Campanile, M., Sardelli, L., Tunesi, M., Fusco, F., Giordano, C., & Albani, D. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105614 · Cited by 11
“3 been also hypothesized that microbiota may reduce the inflammatory response through the endocannabinoid pathway (Alger, 2004; Cani et al., 2016).”
Clark, T. (2020) · Cannabis and Cannabinoid Research · doi:10.1089/can.2019.0095 · Cited by 8
“The gut microbial flora interacts closely with the ECs and plays an important role in metabolism.(40) Changes in the intestinal microbial flora, including a shift in the ratio of Firmicutes:Bacteroidetes, are correlated with obesity.”
BackgroundMehmood, K., Moin, A., Hussain, T., Rizvi, S. M. D., Gowda, D., Shakil, S., & Kamal, M. (2021) · Folia Microbiologica · doi:10.1007/s12223-021-00926-5 · Cited by 11
Castonguay-Paradis, S., Parent, L., St‐Arnaud, G., Perron, J., Dumais, É., Flamand, N., Raymond, F., Marzo, V. D., & Veilleux, A. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae586 · Cited by 10
Mariane Lutz, R., Moya, P. R., Gallorio, S., Ríos, U., & Marcelo Arancibia, M. (2024) · Nutrients · doi:10.3390/nu16162578 · Cited by 12
“GM also generates neuroactive metabolites, such as serotonin and gamma-aminobutyric acid (GABA), that affect central appetite control [47] and can stimulate other systems, such as the endocannabinoid [48].”
BackgroundCampanale, A., Siniscalco, D., & Marzo, V. D. (2025) · Journal of Biomedical Science · doi:10.1186/s12929-025-01145-7 · Cited by 13
The nexus of gut microbiota, diet, and health
Bhattarai, S., & Janaswamy, S. (2022) · Functional Food Science · doi:10.31989/ffs.v2i2.885 · Cited by 12
“For example, through mucin synthesis, TJ reassembly, or 25ccluding and ZO-1 upregulation (mice study), the butyrate produced by the gut bacteria improves gut barrier permeability (human colonic epithelial cell line study) [38], Lactobacillus rhamnosus prevents cytokine-induced apoptosis of the intestinal cells (intest…”
BackgroundCannabinoid receptor 2 evolutionary gene loss makes parrots more susceptible to neuroinflammation
Divín, D., Gómez-Samblás, M., Veetil, N. K., Voukali, E., Świderská, Z., Krajzingrová, T., Těšičký, M., Beneš, V., Elleder, D., Bartoš, O., et al. (2022) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2022.1941 · Cited by 10
Grill, M., Hasenoehrl, C., Storr, M., & Schicho, R. (2018) · Medical Cannabis and Cannabinoids · doi:10.1159/000489036 · Cited by 10
Jahani‐Sherafat, S., Azimirad, M., Raeisi, H., Looha, M. A., Tavakkoli, S., Amoli, H. A., Moghim, S., Rostami‐Nejad, M., Yadegar, A., & Zali, M. R. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09273-3 · Cited by 9
Xu, S., Yu, C., Qin, M., Zhang, Y., Jiang, J., Liu, W., Pan, Y., Zhang, S., & Zhao, X. (2025) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.70183 · Cited by 9
Hen-Shoval, D., Weller, A., Weizman, A., & Shoval, G. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19010523 · Cited by 9
Therapeutic potential of CBD in Autism Spectrum Disorder
Pedrazzi, J. F. C., Hassib, L., Ferreira, F. R., Hallak, J. E. C., Del-Bel, E., & Crippa, J. A. S. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.05.002 · Cited by 12
High and Mighty? Cannabinoids and the microbiome in pain
Rea, K., O’Mahony, S. M., & Cryan, J. F. (2021) · Neurobiology of Pain · doi:10.1016/j.ynpai.2021.100061 · Cited by 9
Gut microbiome in non-alcoholic fatty liver disease
Mpountouridis, A., Tsigalou, C., Bezirtzoglou, I., Bezirtzoglou, E., & Stavropoulou, E. (2025) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2024.1534431 · Cited by 12
“Administration of Lactobacillus rhamnosus GG in high-fructose diet mice with NAFLD enhances gut barrier integrity, decreases lipopolysaccharide levels in the portal vein and lessens the release of pro-in fl ammatory cytokines, such as TNF-a , IL-8R and IL-1 b , from the liver, as well as reduce fat…”
Symphony of the gut microbiota and endocannabinoidome: a molecular and functional perspective
Wang, Y., Guo, J., Mao, Z., & Chen, Y. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1566290 · Cited by 9
“This can trigger chronic central nervous system in fl ammation through the vagus nerve and gut endocrine signals, potentially exacerbating AD progression (Cani et al., 2016).”
Cai, M., Xue, S., Zhou, C., Feng, Y., Liu, J., Liu, R., Wang, P., Wang, H., & Peng, Z. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.04.018 · Cited by 9
A Holistic Review of Cannabis and Its Potential Risks and Benefits in Mental Health
Borrego-Ruiz, A., & Borrego, J. J. (2025) · Psychiatry International · doi:10.3390/psychiatryint6030092 · Cited by 13
Wiącek, J., Podgórski, T., Kusy, K., Łoniewski, I., Skonieczna‐Żydecka, K., & Karolkiewicz, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115611 · Cited by 9
“Alongside the endocannabinoid system (ECS), the gut microbiota (GM) emerges as a critical factor capable of modulating immune functions and signaling pathways associated with daily well-being [9].”
BackgroundThe Bidirectional Interplay Between Substances of Abuse and Gut Microbiome Homeostasis
Borrego-Ruiz, A., & Borrego, J. J. (2025) · Life · doi:10.3390/life15060834 · Cited by 12
“Considering that the most common method of human consumption of cannabis is via smoking, a paucity of studies has been performed on the effects of this substance on the GM. Cani et al. [143] established that exogenic cannabinoids and the ECS regulate the GM.”
Circulating Endocannabinoids as Diagnostic Markers of Canine Chronic Enteropathies: A Pilot Study
Febo, E., Crisi, P. E., Oddi, S., Pietra, M., Galiazzo, G., Piscitelli, F., Gramenzi, A., Prinzio, R. D., Tommaso, M. D., Bernabò, N., et al. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.655311 · Cited by 8
“It can be proposed that eCBs and their congeners play a role of controllers through a CB1-dependent mechanism (55) and in vitro studies showed that AEA might improve mucosal healing in patients with IBD (56), while a protective effect of PEA has been demonstrated in human biopsies from patients with active UC (57).”
BackgroundAbolghasemi, A., Manca, C., Iannotti, F. A., Shen, M., Leblanc, N., Lacroix, S., Martin, C., Flamand, N., Marzo, V. D., & Silvestri, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212361 · Cited by 8
Microbiota–Gut–Brain Axis: Pathophysiological Mechanism in Neuropsychiatric Disorders
Shin, C., & Kim, Y. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_2 · Cited by 10
Microbiome and Colorectal Cancer
Ahmed, I., & Umar, S. (2018) · Current Colorectal Cancer Reports · doi:10.1007/s11888-018-0416-7 · Cited by 8
Monge-Loría, M., Zhong, W., Abrahamse, N. H., Hartter, S., & Garg, N. (2025) · Biochemistry · doi:10.1021/acs.biochem.4c00706 · Cited by 6
Roussel, C., Lessard‐Lord, J., Nallabelli, N., Müller, C. E., Flamand, N., Silvestri, C., & Marzo, V. D. (2025) · The FASEB Journal · doi:10.1096/fj.202500752rr · Cited by 7
Vigano, M., Kubal, S., Lu, Y., Habib, S., Samarani, S., Cama, G., Viau, C., Farzin, H., Koudieh, N., Xia, J., et al. (2024) · Pharmaceuticals · doi:10.3390/ph17070834 · Cited by 7
Akkermansia muciniphila, une bactérie pour lutter contre le syndrome métabolique
Plovier, H., & Cani, P. D. (2017) · médecine/sciences · doi:10.1051/medsci/20173304002 · Cited by 7
“La perturbation de ce microbiote, appelée dysbiose, intervient dans l’émergence du syndrome métabolique [3].”
BackgroundDiet in Intestinal Fibrosis: A Double-Edged Sword
Marion‐Letellier, R., Leboutte, M., Amamou, A., Raman, M., Savoye, G., & Ghosh, S. K. (2021) · Nutrients · doi:10.3390/nu13093148 · Cited by 7
“By its dual role in intestinal inflammation and metabolic disorders, the endocannabinoid system may be a relevant target in the context of intestinal fibrosis [67].”
BackgroundVago, R., Fiorio, F., Trevisani, F., Salonia, A., Montorsi, F., & Bettiga, A. (2022) · Nutrients · doi:10.3390/nu14030468 · Cited by 7
“A higher ECS tone has been associated with an increase in gut permeability and treatment with a CB1 agonist HU-210 induced, as a consequence, severe metabolic disturbances such as glucose intolerance, lipid accumulation in the muscle and endotoxemia [79].”
BackgroundŁukowski, W. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1576419 · Cited by 6
“Detailed understanding of ECBoM ’ s molecular interactions and pathophysiological mechanisms provides a compelling framework for novel preventive and therapeutic strategies, marking a potential paradigm shift in the management of autoimmune diabetes (4, 12, 31).”
InfluentialThe Impact of Environmental Factors on the Secretion of Gastrointestinal Hormones
Smarkusz-Zarzecka, J., Ostrowska, L., & Radziszewska, M. (2025) · Nutrients · doi:10.3390/nu17152544 · Cited by 6
“These sub-stances exhibit anti-inflammatory effects and influence GLP-1 and GLP-2 secretion [58,59].”
Immunomodulation aspects of gut microbiome-related interventional strategies in colorectal cancer
Cheraghpour, M., Fatemi, N., Shadnoush, M., Talebi, G., Tierling, S., & Bermúdez‐Humarán, L. G. (2024) · Medical Oncology · doi:10.1007/s12032-024-02480-9 · Cited by 6
“…of CRC through various mechanisms, such as modulation of immune cells, induction of an inflammatory state, modification and/or self-renewal of cancer stem cells, production of harmful microbial products, including metabolites or genotoxins, and altered metabolism caused by dietary components [14].”
Prete, R., Merola, C., García-González, N., Fanti, F., Angelozzi, G., Sergi, M., Battista, N., Perugini, M., & Corsetti, A. (2024) · Scientific Reports · doi:10.1038/s41598-024-70053-x · Cited by 6
“…findings indicate that oral supplementation of Lactobacillus acidophilus probiotics can positively influence the mRNA expression of cnr1 receptor 50 as well as it has been observed that gut barrier integrity is modulated through a CB1-dependent mechanism following probiotic administration 51,52 .”
BackgroundCao, W., Li, R. W., Chin, Y., Wang, Y., Xue, C., & Tang, Q. (2021) · Food & Function · doi:10.1039/d0fo02556a · Cited by 6
Wardill, H. R., Wooley, L. T., Bellas, O. M., Cao, K., Cross, C., van Dyk, M., Kichenadasse, G., Bowen, J. M., Zannettino, A. C. W., Shakib, S., et al. (2023) · British Journal of Cancer · doi:10.1038/s41416-023-02466-w · Cited by 6
“An emerging area of interest with respect to the gastrointestinal microenvironment is the interaction between the ECS, cannabis and the gut microbiota [43, 75, 76].”
BackgroundHe, Z., Liu, Y., Li, Z., Sun, T., Li, Z., Liu, C., & Xiang, H. (2024) · Neurochemical Research · doi:10.1007/s11064-024-04182-0 · Cited by 5
Bouassa, R. M., Giorgini, G., Silvestri, C., Muller, C., Nallabelli, N., Alexandrova, Y., Durand, M., Tremblay, C. L., Far, M. E., Chartrand‐Lefebvre, C., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110456 · Cited by 5
Yılmaz, C., Kocadağlı, T., & Gökmen, V. (2023) · Food Chemistry · doi:10.1016/j.foodchem.2023.136766 · Cited by 5
Kocadağlı, T., Yılmaz, C., & Gökmen, V. (2024) · Food Chemistry · doi:10.1016/j.foodchem.2024.140164 · Cited by 5
Revisão Bibliográfica Sistematica - Sistema de Endocanabinoides Tendências de Uso na Farmacologia
Corrêa, L. T., Plata, C. F., Ricci, E. L., Nicoletti, M. A., Caperuto, É. C., Spinosa, H. D. S., Munõz, J. W. P., & Fukushima, A. R. (2020) · Brazilian Journal of Forensic Science Medical Law and Bioethics · doi:10.17063/bjfs9(2)y2020146 · Cited by 5
Kim, D., Min, Y., Suminda, G. G. D., Hur, C.-G., Lee, S.-C., Lee, H., Song, K., Heo, J.-Y., Son, Y., & Lee, D. (2022) · Animal Biotechnology · doi:10.1080/10495398.2022.2047996 · Cited by 5
“Immune cells can recognize the peptidoglycan of resident microorganisms through NOD1 or TLR to elicit an innate immune response.(49) TLR-4 is an essential member of the TLR family and is involved in different inflammatory reactions; it transmits signals via MYD88 dependent or independent pathways.”
BackgroundMicrobial Impact on Host Metabolism: Opportunities for Novel Treatments of Nutritional Disorders?
Plovier, H., & Cani, P. D. (2018) · ASM Press eBooks · doi:10.1128/9781555819705.ch5 · Cited by 5
Pedrazzi, J. F. C., Hassib, L., & Ferreira, F. R. (2023) · Psychiatric Annals · doi:10.3928/00485713-20230515-01 · Cited by 4
Jahani‐Sherafat, S., Azimirad, M., Ghasemian-Safaei, H., Amoli, H. A., Moghim, S., Sherkat, G., & Zali, M. R. (2019) · Gastroenterology and hepatology from bed to bench. · Cited by 4
Tao, K., Zhu, J., Wei, K., Meng, X., Zhu, M., Tao, Y. K., Lu, Z., & Yu, W. (2021) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005405 · Cited by 4
The Role of the Gut Microbiome in Bipolar Disorder and its Common Medical Comorbidities
Jones, G. H., Pinjari, O. F., Vecera, C. M., Smith, K., Barrera, A., & Machado‐Vieira, R. (2023) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2023.101078 · Cited by 5
Marcellin, F., Fontaine, H., Serfaty, L., Sogni, P., & Carrieri, P. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2018.1473764 · Cited by 4
“regulation of energy homeostasis, inflammation, and gut permeability [4].”
BackgroundResultInfluentialGut Microbiota; Its Importance in Obesity
Muñoz‐Garach, A., Cornejo-Pareja, I. M., & Tinahones, F. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65351-5 · Cited by 4
de Almeida, M. M., Calviño, C., Reis-Gomes, C. F., Lombardi, I., Brand, A. L. M., Pazos-Moura, C. C., Garrett, R., Alves, M. A., & Trevenzoli, I. H. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109802 · Cited by 4
Maki, K. A., Barb, J. J., Xu, S., Papneja, S., Alkhatib, J., Butera, G., & Wallen, G. R. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106609 · Cited by 5
Microbiota-driven gut-brain signaling underlies antidepressant effects of a GLP-1 analog
Bian, L., Cai, Y., Zhang, Y., Shen, L., Wang, H., Gao, F., Cai, N., Chen, W., You, C., Yang, Y., et al. (2026) · Cell Host & Microbe · doi:10.1016/j.chom.2026.05.003 · Cited by 3
Vari, F., Serra, I., Friuli, M., Cavallo, V., Gammaldi, N., Vergara, D., Salzet, M., & Giudetti, A. M. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1567543 · Cited by 4
Endocannabinoid and AGE Interactions in Prediabetes: The Role of Mediterranean Diet Adherence
Grahovac, M., Kumrić, M., Vilović, M., Šupe‐Domić, D., Pavlović, N., Bukić, J., Kurir, T. T., & Božić, J. (2025) · Nutrients · doi:10.3390/nu17152517 · Cited by 5
“These nutrients may act through altered fatty acid profiles, reduced oxidative stress, or shifts in the gut microbiota [40,52].”
Sharkey, K. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821597-5.00003-4 · Cited by 3
O’Brien, K., & Blair, P. (2021) · Springer eBooks · doi:10.1007/978-3-030-78559-8_10 · Cited by 4
Wang, J., Xu, B., Zhang, Z., Zhou, L., Zhang, G., Zhang, Y., & Wang, C. (2022) · Animals · doi:10.3390/ani12030342 · Cited by 3
Impact of bioactive lipids on gut microbiota
Salsinha, A. S., & Pintado, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824043-4.00008-7 · Cited by 3
Chevalier, G., Siopi, E., Guenin‐Macé, L., Pascal, M., Laval, T., Rifflet, A., Boneca, I. G., Demangel, C., Leulier, F., Lepousez, G., et al. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/718288 · Cited by 3
Ortiz-Alvarez, L., Xu, H., Di, X., Köhler, I., Osuna‐Prieto, F. J., Acosta, F. M., Vilchez‐Vargas, R., Link, A., Plaza‐Díaz, J., van der Stelt, M., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4000450 · Cited by 3
Giorgini, G., Silvestri, C., Bouassa, R. M., Muller, C., Boligan, K. F., Kalkan, H., Routy, J., Flamand, N., Marzo, V. D., Jenabian, M.-A., et al. (2025) · Cannabis and Cannabinoid Research · doi:10.1177/25785125251366052 · Cited by 2
Pech-Jiménez, C., Carrera-Quintanar, L., Paredes, J. M. V., Márquez‐Sandoval, F., Jave‐Suárez, L. F., Zepeda‐Morales, A. S. M., Velázquez‐Juárez, G., & López-Roa, R. I. (2025) · Metabolites · doi:10.3390/metabo15100638 · Cited by 2
“This disruption not only compromises the integrity of the intestinal barrier by favoring endotoxin translocation and inflammation [44,45], but could also interfere with the pharmacodynamics of BCP. Previous studies support this hypothesis, demonstrating that BCP possesses selective antimicrobial…”
Tagliamonte, S., Lumaga, R. B., Filippis, F. D., Valentino, V., Aponte, M., Romano, R., & Vitaglione, P. (2025) · Current Research in Food Science · doi:10.1016/j.crfs.2025.101215 · Cited by 2
“…compared to conventional pasta (ConP), by improving gut barrier integrity and influencing lipid mediators, such as endocannabinoids (ECs) and N-acylethanolamines (NAEs), which are key regulators of appetite, energy metabolism, and host-microbiota interactions (Witkamp, 2018, Cani et al., 2016).”
Vecchiarelli, H. A., Baglot, S. L., Black, T., Choi, E. Y., Cupo, L., Sandberg, C., Siron, L., Chakravarty, M. M., Hill, M. N., Howland, J. G., et al. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106488 · Cited by 3
Mo, M., Chen, X., Liu, Y., Wang, C., Chen, X., Zhang, N., He, N., Li, Y., Wang, J., Chen, H., et al. (2025) · Advanced Science · doi:10.1002/advs.202507695 · Cited by 2
Significance of neuroendocrine systems and the gut-brain axis (GBA) in the regulation of obesity
Zhao, H., Li, Y., Cheng, R., Wang, Y., Ma, L., & Chen, W. (2026) · PeerJ · doi:10.7717/peerj.20400 · Cited by 3
Degraeve, A. L., Cutignano, A., Piscitelli, F., Villano, R., Simone, G. D., Verde, R., Thibaut, M. M., Bindels, L. B., & Marzo, V. D. (2026) · BJC Reports · doi:10.1038/s44276-026-00208-y · Cited by 2
“Likewise, eCB levels are elevated in the liver of mice with steatosis [14, 15] and in the small and large intestine of mice and rats with obesity [16, 17] and disrupted food intake, altered intestinal epithelial barrier, and gut microbiome dysbiosis [18, 19].”
The Hidden Metabolic Roots of Epilepsy
Rubio, C., Carpinteyro, S., Serrano‐García, N., Parra, H. R., Pérez-Villavicencio, J., Lee, Á., Mercado-Pimentel, R., & Rubio‐Osornio, M. (2026) · Biomedicines · doi:10.3390/biomedicines14040764 · Cited by 2
“Endocrine hormones released by gastrointestinal and adipose tissues, including ghrelin, leptin, and adiponectin, regulate neuronal excitability within this axis [92,134].”
Endocannabinoids Attenuate the Virulence of Certain Enteropathogenic Bacteria
Osman, M., Papon, N., & Weill, F. (2020) · Trends in Microbiology · doi:10.1016/j.tim.2020.12.008 · Cited by 2
Iseli, G. C., Ulrich, S., & Schmidt, A. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1098019 · Cited by 2
“, CBD), which are interacting with the gut microbiome (102, 103) and have anti-(neuro)inflammatory and anti-(neuro)oxidative central properties (104).”
BackgroundLacroix, S., Leblanc, N., Abolghasemi, A., Paris-Robidas, S., Martin, C., Frappier, M., Flamand, N., Silvestri, C., Raymond, F., Millette, M., et al. (2023) · Beneficial Microbes · doi:10.3920/bm2022.0080 · Cited by 2
Metadata
- Authors
- Cani, P. D., Plovier, H., Van Hul, M., Geurts, L., Delzenne, N. M., Druart, C., & Everard, A.
- Affiliations
- Walloon Excellence in Lifesciences and Biotechnology (BE)
- UCLouvain (BE)
- Corresponding author
- Cani, Patrice D.
- ORCID
- Venue
- Nature Reviews Endocrinology
- Published
- 2015-12-18
- Volume
- 12
- Issue
- 3
- Pages
- 133-143
- ISSN
- 1759-5029 (ISSN-L)
- 1759-5037
- OpenAlex
- W2206708469
- Cited by
- 367
- References
- 156
- Citations by year
- 2026: 23 · 2025: 30 · 2024: 27 · 2023: 37 · 2022: 51 · 2021: 55 · 2020: 45 · 2019: 25 · 2018: 30 · 2017: 24 · 2016: 20
- FWCI
- 3.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Libraries (submittedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- endocannabinoid system, gut microbiota, host metabolism, intestinal permeability, intestinal barrier, bioactive lipids, obesity, adipose tissue, type 2 diabetes, cardiometabolic disease, intestinal inflammation, fat mass
- MeSH terms
- Gastrointestinal Microbiome, Animals, Humans, Gastrointestinal Tract, Receptors, Cannabinoid, Endocannabinoids
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review